Maternal Multiple Sclerosis and Offspring's Developmental andBehavioral Profile: A Case-control Study
Offspring's developmental and behavioral phenotypes do not appear to be influenced by maternal treatment with Natalizumab until late pregnancy, nor by maternal variables directly related to MS (age at the time of MS diagnosis, disease duration, and severity).
Authors
- Francesca Napoli (ORCID: https://orcid.org/0000-0002-9745-998X)
- Cinzia Niolu (ORCID: https://orcid.org/0000-0001-6173-2684)
- Lucrezia Arturi (ORCID: https://orcid.org/0000-0002-3232-5286)
- Doriana Landi (ORCID: https://orcid.org/0000-0002-3309-8417)
- Chiara Scoppola
- Luigi Mazzone (ORCID: https://orcid.org/0000-0002-5287-3386)
- Elisa Carloni (ORCID: https://orcid.org/0000-0001-7636-6656)
- Martina Siracusano (ORCID: https://orcid.org/0000-0002-3357-1788)
- Marialaura Ferrara
- Assia Riccioni (ORCID: https://orcid.org/0000-0001-6496-8756)
- Mariagrazia Cicala
- Leonardo Emberti Gialloreti
- Girolama Alessandra Marfia
Institutions
- University of Rome Tor Vergata (IT)
- Policlinico Tor Vergata (IT)
Publication Details
- Journal
- Current Neuropharmacology
- Published
- 2025-07-04
- DOI
- https://doi.org/10.2174/011570159x370866250416103923
- Primary Topic
- Family Support in Illness
- Type
- article
- Field-Weighted Citation Impact
- 0.00